{{Rsnum
|rsid=465646
|Gene=REV3L
|Chromosome=6
|position=111299555
|Orientation=plus
|GMAF=0.2034
|Gene_s=REV3L
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 78.5 | 20.0 | 1.5
| HCB | 71.1 | 26.7 | 2.2
| JPT | 63.6 | 27.3 | 9.1
| YRI | 52.4 | 41.3 | 6.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 71.1 | 26.7 | 2.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22349819
|Title=REV3L 3'UTR 460 T>C polymorphism in microRNA target sites contributes to lung cancer susceptibility.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}